Significance of conversation between mast cells and nerves

Allergy, Asthma and Clinical Immunology

Volumn 1, Issue 2, 2005, Pages 65-80

  Van Der Kleij, Hanneke P M ^b   Bienenstock, John ^a  

^a MCMASTER UNIVERSITY   (Canada)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

BETA 2 ADRENERGIC RECEPTOR STIMULATING AGENT; CORTICOSTEROID DERIVATIVE; CYCLOSPORIN A; GROWTH FACTOR; NEUROKININ 1 RECEPTOR; NEUROPEPTIDE; TACHYKININ DERIVATIVE;

AIRWAY; ASTHMA; ATOPIC DERMATITIS; CELL ACTIVATION; CELL COMMUNICATION; CELL STRUCTURE; EOSINOPHIL; GASTROINTESTINAL TRACT; HUMAN; IMMUNE SYSTEM; LANGERHANS CELL; MAST CELL; MAST CELL DEGRANULATION; NERVE; NERVE FIBER; NERVOUS SYSTEM; NEUROGENIC INFLAMMATION; NONHUMAN; PATHOGENESIS; PLASMA CELL; REVIEW; SKIN; UNSPECIFIED SIDE EFFECT;

EID: 33748521527     PISSN: 17101484     EISSN: None     Source Type: Journal    
DOI: 10.2310/7480.2005.00015     Document Type: Review

References (150)

1. Marshall JS, Waserman S. Mast cells and the nerves-potential interactions in the context of chronic disease. Clin Exp Allergy 1995;25:102-10.
2. van der Kleij HPM, Blennerhassett M, Bienenstock J. Nerve-mast cell interactions-partnership in health and disease. In: Bienenstock J, Blennerhassett M, Goetzl E, editors. Autonomic neuroimmunology. Autonomic Neuroscience Series. Vol. 15. London, (UK): Taylor&Francis group; 2003 p. 139-170.
3. Purcell WM, Atterwill CK. Mast cells in neuroimmune function: neurotoxicological and neuropharmacological perspectives. Neurochem Res 1995;20:521-32.
4. Arizono N, Matsuda S, Hattori T, et al. Anatomical variation in mast cell nerve associations in the rat small intestine, heart, lung, and skin: similarities of distances between neural processes and mast cells, eosinophils, or plasma cells in the jejunal lamina propria. Lab Invest 1990;62:626-34.
5. Bienenstock J, MacQueen G, Sestini P, et al. Mast cell/nerve interactions in vitro and in vivo. Am Rev Respir Dis 1991;143:S55-8.
6. Pang X, Boucher W, Triadafilopoulos G, et al. Mast cell and substance P-positive nerve involvement in a patient with both irritable bowel syndrome and interstitial cystitis. Urology 1996;47:436-8.
7. Bauer O, Razin E. Mast cell-nerve interactions. New Physiol Sci 2000;15:213-8.
8. Stead RH, Tomioka M, Quinonez G, et al. Intestinal mucosal mast cells in normal and nematode-infected rat intestines are in intimate contact with peptidergic nerves. Proc Natl Acad Sci USA 1987;84:2975-9.
9. Undem BJ, Riccio MM, Weinreich D, et al. Neurophysiology of mast cell-nerve interactions in the airways. Int Arch Allergy Immunol 1995;107:199-201.
10. Egan CL, Viglione-Schneck MJ, Walsh LJ, et al. Characterization of unmyelinated axons uniting epidermal and dermal immune cells in primate and murine skin. J Cutan Pathol 1998;25:20-9.
11. Letourneau R, Pang X, Sant GR, Theoharides TC. Intragranular activation of bladder mast cells and their association with nerve processes in interstitial cystitis. Br J Urol 1996;77:41-54.
12. Keller JT, Marfurt CF. Peptidergic and serotoninergic innervation of the rat dura mater. J Comp Neurol 1991;309:115-34.
13. Olsson Y. Mast cells in the nervous system. Int Rev Cytol 1968;24:27-70.
14. Newson B, Dahlstrom A, Enerback L, Ahlman H. Suggestive evidence for a direct innervation of mucosal mast cells. Neuroscience 1983;10:565-70.
15. Pothoulakis C, Castagliuolo I, Leeman SE. Neuroimmune mechanisms of intestinal responses to stress. Role of corticotropin-releasing factor and neurotensin. Ann N Y Acad Sci 1998;840:635-48.
16. Santos J, Saunders PR, Hanssen NP, et al. Corticotropin-releasing hormone mimics stress-induced colonic epithelial pathophysiology in the rat. Am J Physiol 1999;277:G391-9.
17. Santos J, Benjamin M, Yang PC, et al. Chronic stress impairs rat growth and jejunal epithelial barrier function: role of mast cells. Am J Physiol Gastrointest Liver Physiol 2000;278:G847-54.
18. Kraneveld AD, van der Kleij HP, Kool M, et al. Key role for mast cells in nonatopic asthma. J Immunol 2002;169:2044-53.
19. Rozniecki JJ, Dimitriadou V, Lambracht-Hall M, et al. Morphological and functional demonstration of rat dura mater mast cell-neuron interactions in vitro and in vivo. Brain Res 1999;849:1-15.
20. Bradding P, Holgate ST. Immunopathology and human mast cell cytokines. Crit Rev Oncol Hematol 1999;31:119-31.
21. Malaviya R, Ikeda T, Ross E, Abraham SN. Mast cell modulation of neutrophil influx and bacterial clearance at sites of infection through TNF-alpha. Nature 1996;381:77-80.
22. Maurer M, Fischer E, Handjiski B, et al. Activated skin mast cells are involved in murine hair follicle regression (catagen). Lab Invest 1997;77:319-32.
23. Maurer M, Paus R, Czarnetzki BM. Mast cells as modulators of hair follicle cycling. Exp Dermatol 1995;4:266-71.
24. Welle M. Development, significance, and heterogeneity of mast cells with particular regard to the mast cell-specific proteases chymase and tryptase. J Leukoc Biol 1997;61:233-45.
25. Beil WJ, Schulz M, Wefelmeyer U. Mast cell granule composition and tissue location-a close correlation. Histol Histopathol 2000;15:937-46.
26. Befus AD, Dyck N, Goodacre R, Bienenstock J. Mast cells from the human intestinal lamina propria. Isolation, histochemical subtypes, and functional characterization. J Immunol 1987;138:2604-10.
27. Galli SJ. New insights into "the riddle of the mast cells": microenvironmental regulation of mast cell development and phenotypic heterogeneity. Lab Invest 1990;62:5-33.
28. Church MK, Clough GF. Human skin mast cells: in vitro and in vivo studies. Ann Allergy Asthma Immunol 1999;83:471-5.
29. Kitamura Y, Kanakura Y, Sonoda S, et al. Mutual phenotypic changes between connective tissue type and mucosal mast cells. Int Arch Allergy Appl Immunol 1987;82:244-8.
30. Church MK, Levi-Schaffer F. The human mast cell. J Allergy Clin Immunol 1997:99;155-60.
31. Gordon JR, Galli SJ. Mast cells as a source of both preformed and immunologically inducible TNF-alpha/cachectin. Nature 1990:346;274-6.
32. Junger H, Sorkin LS. Nociceptive and inflammatory effects of subcutaneous TNF alpha. Pain 2000;85:145-51.
33. Nicol GD, Lopshire JC, Pafford CM. Tumor necrosis factor enhances the capsaicin sensitivity of rat sensory neurons. J Neurosci 1997;17:975-82.
34. Aranguez I, Torres C, Rubio N. The receptor for tumor necrosis factor on murine astrocytes: characterization, intracellular degradation, and regulation by cytokines and Theiler's murine encephalomyelitis virus. Glia 1995;13:185-94.
35. Dopp JM, Mackenzie-Graham A, Otero GC, Merrill JE. Differential expression, cytokine modulation, and specific functions of type-1 and type-2 tumor necrosis factor receptors in rat glia. J Neuroimmunol 1997;75:104-12.
36. Mirza H, Schmidt VA, Derian CK, et al. Mitogenic responses mediated through the proteinase-activated receptor-2 are induced by expressed forms of mast cell alpha- or beta-tryptases. Blood 1997;90:3914-22.
37. Defea K, Schmidlin F, Dery O, et al. Mechanisms of initiation and termination of signalling by neuropeptide receptors: a comparison with the proteinase-activated receptors. Biochem Soc Trans 2000;28:419-26.
38. Corvera CU, Dery O, McConalogue K, et al. Thrombin and mast cell tryptase regulate guineapig myenteric neurons through proteinase-activated receptors-1 and -2. J Physiol 1999;517:741-56.
39. Marshall JS, Gomi K, Blennerhassett MG, Bienenstock J. Nerve growth factor modifies the expression of inflammatory cytokines by mast cells via a prostanoid-dependent mechanism. J Immunol 1999;162:4271-6.
40. Horigome K, Pryor JC, Bullock ED, Johnson EM. Mediator release from mast cells by nerve growth factor. Neurotrophin specificity and receptor mediation. J Biol Chem 1993;268:14881-7.
41. Lindsay RM, Harmar AJ. Nerve growth factor regulates expression of neuropeptide genes in adult sensory neurons. Nature 1989;337:362-4.
42. Aloe L, Levi-Montalcini R. Nerve growth factor induced overgrowth of axotomized superior cervical ganglia in neonatal rats. Similarities and differences with NGF effects in chemically axotomized sympathetic ganglia. Arch Ital Biol 1979;117:287-307.
43. Pearce FL, Thompson HL. Some characteristics of histamine secretion from rat peritoneal mast cells stimulated with nerve growth factor. J Physiol 1986;372:379-93.
44. Aloe L. The effect of nerve growth factor and its antibody on mast cells in vivo. J Neuroimmunol 1988;18:1-12.
45. Leon A, Buriani A, Dal Toso R, et al. Mast cells synthesize, store, and release nerve growth factor. Proc Natl Acad Sci USA 1994;91:3739-43.
46. Marshall JS, Stead RH, McSharry C, et al. The role of mast cell degranulation products in mast cell hyperplasia. I. Mechanism of action of nerve growth factor. J Immunol 1990;144:1886-92.
47. Braun A, Quarcoo D, Schulte-Herbruggen O, et al. Nerve growth factor induces airway hyperresponsiveness in mice. Int Arch Allergy Immunol 2001;124:205-7.
48. Braun A, Lommatzsch M, Lewin GR, et al. Neurotrophins: a link between airway inflammation and airway smooth muscle contractility in asthma? Int Arch Allergy Immunol 1999;118:163-5.
49. Villoslada P, Hauser SL, Bartke I, et al. Human nerve growth factor protects common marmosets against autoimmune encephalomyelitis by switching the balance of T helper cell type 1 and 2 cytokines within the central nervous system. J Exp Med 2000;191:1799-806.
50. Flugel A, Matsumuro K, Neumann H, et al. Anti-inflammatory activity of nerve growth factor in experimental autoimmune encephalomyelitis: inhibition of monocyte transendothelial migration. Eur J Immunol 2001;31:11-22.
51. Mousli M, Bronner C, Bockaert J, et al. Interaction of substance P, compound 48/80, and mastoparan with the alpha-subunit C-terminus of G protein. Immunol Lett 1990;25:355-7.
52. Mousli M, Hugli TE, Landry Y, Bronner C. Peptidergic pathway in human skin and rat peritoneal mast cell activation. Immunopharmacology 1994;27:1-11.
53. Severini C, Improta G, Falconieri-Erspamer G, et al. The tachykinin peptide family. Pharmacol Rev 2002;54:285-322.
54. Nakanishi S. Mammalian tachykinin receptors. Annu Rev Neurosci 1991;14:123-36.
55. Regoli D, Boudon A, Fauchere JL. Receptors and antagonists for substance P and related peptides. Pharmacol Rev 1994;46:551-99.
56. Kaltreider HB, Ichikawa S, Byrd PK, et al. Upregulation of neuropeptides and neuropeptide receptors in a murine model of immune inflammation in lung parenchyma. Am J Respir Cell Mol Biol 1997;16:133-44.
57. Mantyh CR, Vigna SR, Bollinger RR, et al. Differential expression of substance P receptors in patients with Crohn's disease and ulcerative colitis. Gastroenterology 1995;109:850-60.
58. Karimi K, Redegeld FA, Blom R, Nijkamp FP. Stem cell factor and interleukin-4 increase responsiveness of mast cells to substance P. Exp Hematol 2000;28:626-34.
59. Cooke HJ, Fox P, Alferes L, et al. Presence of NK1 receptors on a mucosal-like mast cell line, RBL-2H3 cells. Can J Physiol Pharmacol 1998;76:188-93.
60. Okada T, Hirayama Y, Kishi S, et al. Functional neurokinin NK-1 receptor expression in rat peritoneal mast cells. Inflamm Res 1999;48:274-9.
61. Suzuki R, Furuno T, McKay DM, et al. Direct neurite-mast cell communication in vitro occurs via the neuropeptide substance P. J Immunol 1999;163:2410-5.
62. Mori N, Suzuki R, Furuno T, et al. Nerve-mast cell (RBL) interaction: RBL membrane ruffling occurs at the contact site with an activated neurite. Am J Physiol Cell Physiol 2002;283: C1738-44.
63. van der Kleij HP, Ma D, Redegeld FA, et al. Functional expression of neurokinin 1 receptors on mast cells induced by IL-4 and stem cell factor. J Immunol 2003;171:2074-9.
64. Furuno T, Ma D, van der Kleij HP, et al. Bone marrow-derived mast cells in mice respond in co-culture to scorpion venom activation of superior cervical ganglion neuritis according to level of expression of NK-1 receptors. Neurosci Lett 2004;372:185-9.
65. Bischoff SC, Schwengberg S, Lorentz A, et al. Substance P and other neuropeptides do not induce mediator release in isolated human intestinal mast cells. Neurogastroenterol Motil 2004;16:185-93.
66. Biro T, Maurer M, Modarres S, et al. Characterization of functional vanilloid receptors expressed by mast cells. Blood 1998;91:1332-40.
67. Paus R, Heinzelmann T, Robicsek S, et al. Substance P stimulates murine epidermal keratinocyte proliferation and dermal mast cell degranulation in situ. Arch Dermatol Res 1995;287:500-2.
68. Barnes PJ. Neurogenic inflammation and asthma. J Asthma 1992;29:165-80.
69. Holzer P. Local effector functions of capsaicin-sensitive sensory nerve endings: involvement of tachykinins, calcitonin gene-related peptide and other neuropeptides. Neuroscience 1988;24:739-68.
70. Paus R, Peters EM, Eichmuller S, Botchkarev VA. Neural mechanisms of hair growth control. J Investig Dermatol Symp Proc 1997;2:61-8.
71. Gottwald T, Coerper S, Schaffer M, et al. The mast cell-nerve axis in wound healing: a hypothesis. Wound Repair Regen 1998;6:8-20.
72. Singh LK, Pang X, Alexacos N, et al. Acute immobilization stress triggers skin mast cell degranulation via corticotropin-releasing hormone, neurotensin, and substance P: a link to neurogenic skin disorders. Brain Behav Immun 1999;13:225-39.
73. Echtenacher B, Mannel DN, Hultner L. Critical protective role of mast cells in a model of acute septic peritonitis. Nature 1996;381:75-7.
74. Murphy PG, Borthwick LS, Johnston RS, et al. Nature of the retrograde signal from injured nerves that induces interleukin-6 mRNA in neurons. J Neurosci 1999:19;3791-800.
75. Nemmar A, Delaunois A, Beckers JF, et al. Modulatory effect of imetit, a histamine H3 receptor agonist, on C-fibers, cholinergic fibers, and mast cells in rabbit lungs in vitro. Eur J Pharmacol 1999;371:23-30.
76. Sekizawa S, Tsubone H, Kuwahara M, Sugano S. Does histamine stimulate trigeminal nasal afferents? Respir Physiol 1998;112:13-22.
77. Imamura M, Smith NC, Garbarg M, Levi R. Histamine H3-receptor-mediated inhibition of calcitonin gene-related peptide release from cardiac C fibers. A regulatory negative-feedback loop. Circ Res 1996;78:863-9.
78. Kashiba H, Fukui H, Morikawa Y, Senba E. Gene expression of histamine H1 receptor in guinea pig primary sensory neurons: a relationship between H1 receptor mRNA-expressing neurons and peptidergic neurons. Brain Res Mol Brain Res 1999;66:24-34.
79. Shubayev VI, Myers RR. Axonal transport of TNF-alpha in painful neuropathy: distribution of ligand tracer and TNF receptors. J Neuroimmunol 2001;114:48-56.
80. Fischer A, McGregor GP, Saria A, et al. Induction of tachykinin gene and peptide expression in guinea pig nodose primary afferent neurons by allergic airway inflammation. J Clin Invest 1996;98:2284-91.
81. Undem BJ, Hubbard W, Weinreich D. Immunologically induced neuromodulation of guinea pig nodose ganglion neurons. J Auton Nerv Syst 1993;44:35-44.
82. Barnes PJ. Neurogenic inflammation in airways. Int Arch Allergy Appl Immunol 1991;94:303-9.
83. Lundberg JM, Brodin E, Hua X, Saria A. Vascular permeability changes and smooth muscle contraction in relation to capsaicin-sensitive substance P afferents in the guinea pig. Acta Physiol Scand 1984;120:217-27.
84. Baluk P. Neurogenic inflammation in skin and airways. J Investig Dermatol Symp Proc 1997;2:76-81.
85. Maggi CA, Giachetti A, Dey RD, Said SI. Neuropeptides as regulators of airway function: vasoactive intestinal peptide and the tachykinins. Physiol Rev 1995;75:277-322.
86. Sann H, Dux M, Schemann M, Jancso G. Neurogenic inflammation in the gastrointestinal tract of the rat. Neurosci Lett 1996;219:147-50.
87. Baraniuk JN, Kowalski ML, Kaliner MA. Relationships between permeable vessels, nerves, and mast cells in rat cutaneous neurogenic inflammation. J Appl Physiol 1990;68:2305-11.
88. Lundberg JM, Martling CR, Sana A. Substance P and capsaicin-induced contraction of human bronchi. Acta Physiol Scand 1983;119:49-53.
89. Sestini P, Dolovich M, Vancheri C, et al. Antigen-induced lung solute clearance in rats is dependent on capsaicin-sensitive nerves. Am Rev Respir Dis 1989;139:401-6.
90. Baird AW, Cuthbert AW. Neuronal involvement in type 1 hypersensitivity reactions in gut epithelia. Br J Pharmacol 1987;92:647-55.
91. Westerman RA, Low A, Pratt A, et al. Electrically evoked skin vasodilatation: a quantitative test of nociceptor function in man. Clin Exp Neurol 1987;23:81-9.
92. Undem BJ, Myers AC, Barthlow H, Weinreich D. Vagal innervation of guinea pig bronchial smooth muscle. J Appl Physiol 1990;69:1336-46.
93. White DM. Release of substance P from peripheral sensory nerve terminals. J Peripher Nerv Syst 1997;2:191-201.
94. Bischoff SC, Baggiolini M, de Weck AL, Dahinden CA. Interleukin 8-inhibitor and inducer of histamine and leukotriene release in human basophils. Biochem Biophys Res Commun 1991;179:628-33.
95. Coleman JW, Holliday MR, Kimber I, et al. Regulation of mouse peritoneal mast cell secretory function by stem cell factor, IL-3 or IL-4. J Immunol 1993;150:556-62.
96. Janiszewski J, Bienenstock J, Blennerhassett MG. Picomolar doses of substance P trigger electrical responses in mast cells without degranulation. Am J Physiol 1994;267:C138-45.
97. van Houwelingen AH, Kool M, de Jager SC, et al. Mast cell-derived TNF-alpha primes sensory nerve endings in a pulmonary hypersensitivity reaction. J Immunol 2002;168:5297-302.
98. Theoharides TC, Kops SK, Bondy PK, Askenase PW. Differential release of serotonin without comparable histamine under diverse conditions in the rat mast cell. Biochem Pharmacol 1985;34:1389-98.
99. Ratliff TL, Klutke CG, Hofmeister M, et al. Role of the immune response in interstitial cystitis. Clin Immunol Immunopathol 1995;74:209-16.
100. Gottwald TP, Hewlett BR, Lhotak S, Stead RH. Electrical stimulation of the vagus nerve modulates the histamine content of mast cells in the rat jejunal mucosa. Neuroreport 1995;7:313-7.
101. Kandere-Grzybowska K, Letourneau R, Kempuraj D, et al. IL-1 induces vesicular secretion of IL-6 without degranulation from human mast cells. J Immunol 2003;171:4830-6.
102. Kraeuter Kops S, Theoharides TC, Cronin CT, et al. Ultrastructural characteristics of rat peritoneal mast cells undergoing differential release of serotonin without histamine and without degranulation. Cell Tissue Res 1990;262:415-24.
103. Payan DG, Levine JD, Goetzl EJ. Modulation of immunity and hypersensitivity by sensory neuropeptides. J Immunol 1984;132:1601-4.
104. Elenkov IJ, Wilder RL, Chrousos GP, Vizi ES. The sympathetic nerve-an integrative interface between two supersystems: the brain and the immune system. Pharmacol Rev 2000;52:595-638.
105. Cromlish JA, Seidah NG, Marcinkiewicz M, et al. Human pituitary tryptase: molecular forms, NH2-terminal sequence, immunocytochemical localization, and specificity with prohormone and fluorogenic substrates, J Biol Chem 1987;262:1363-73.
106. Silver R, Silverman AJ, Vitkovic L, Lederhendler II. Mast cells in the brain: evidence and functional significance. Trends Neurosci 1996;19:25-31.
107. Persinger MA. Brain mast cell numbers in the albino rat: sources variability. Behav Neural Biol 1979;25:380-6.
108. Silverman AJ, Millar RP, King JA, et al. Mast cells with gonadotropin-releasing hormone-like immunoreactivity in the brain of doves. Proc Natl Acad Sci USA 1994;91:3695-9.
109. Matsumoto I, Inoue Y, Shimada T, Aikawa T. Brain mast cells act as an immune gate to the hypothalamic-pituitary-adrenal axis in dogs. J Exp Med 2001;194:71-8.
110. Mares V, Bruckner G, Biesold D. Mast cells in the rat brain and changes in their number under different light regimens. Exp Neurol 1979;65:278-83.
111. MacQueen G, Marshall J, Perdue M, et al. Pavlovian conditioning of rat mucosal mast cells to secrete rat mast cell protease II. Science 1989;243:83-5.
112. Theoharides TC, Singh LK, Boucher W, et al. Corticotropin-releasing hormone induces skin mast cell degranulation and increased vascular permeability, a possible explanation for its proinflammatory effects. Endocrinology 1998;139:403-13.
113. Black PH. Stress and the inflammatory response: a review of neurogenic inflammation. Brain Behav Immun 2002;16:622-53.
114. Castagliuolo I, Wershil BK, Karalis K, et al. Colonic mucin release in response to immobilization stress is mast cell dependent. Am J Physiol 1998;274:G1094-100.
115. Santos J, Saperas E, Nogueiras C, et al. Release of mast cell mediators into the jejunum by cold pain stress in humans. Gastroenterology 1998;114:640-8.
116. Rossi R, Johansson O. Cutaneous innervation and the role of neuronal peptides in cutaneous inflammation: a minireview. Eur J Dermatol 1998;8:299-306.
117. Ansel JC, Armstrong CA, Song I, et al. Interactions of the skin and nervous system. J Investig Dermatol Symp Proc 1997;2:23-6.
118. McDonald DM, Bowden JJ, Baluk P, Bunnett NW. Neurogenic inflammation. A model for studying efferent actions of sensory nerves. Adv Exp Med Biol 1996;410:453-62.
119. Scholzen T, Armstrong CA, Bunnett NW, et al. Neuropeptides in the skin: interactions between the neuroendocrine and the skin immune systems. Exp Dermatol 1998;7:81-96.
120. Church MK, Okayama Y, el-Lati S. Mediator secretion from human skin mast cells provoked by immunological and non-immunological stimulation. Skin Pharmacol 1991;4:15-24.
121. Ansel JC, Brown JR, Payan DG, Brown MA. Substance P selectively activates TNF-alpha gene expression in murine mast cells. J Immunol 1993;150:4478-85.
122. Hart PH, Jaksic A, Swift G, et al. Histamine involvement in UVB- and cis-urocanic acid-induced systemic suppression of contact hypersensitivity responses. Immunology 1997;91:601-8.
123. Hart PH, Grimbaldeston MA, Swift GJ, et al. Dermal mast cells determine susceptibility to ultraviolet B-induced systemic suppression of contact hypersensitivity responses in mice. J Exp Med 1998;187:2045-53.
124. Alard P, Niizeki H, Hanninen L, Streilein JW. Local ultraviolet B irradiation impairs contact hypersensitivity induction by triggering release of tumor necrosis factor-alpha from mast cells: involvement of mast cells and Langerhans cells in susceptibility to ultraviolet B. J Invest Dermatol 1999;113:983-90.
125. Yoshikawa T, Streilein JW. Tumor necrosis factor-alpha and ultraviolet B light have similar effects on contact hypersensitivity in mice. Reg Immunol 1990-91;3:139-44.
126. Solway J, Leff AR. Sensory neuropeptides and airway function. J Appl Physiol 1991;71:2077-87.
127. Ollerenshaw SL, Jarvis D, Sullivan CE, Woolcock AJ. Substance P immunoreactive nerves in airways from asthmatics and nonasthmatics. Eur Respir J 1991;4:673-82.
128. Nieber K, Baumgarten CR, Rathsack R, et al. Substance P and beta-endorphin-like immunoreactivity in lavage fluids of subjects with and without allergic asthma. J Allergy Clin Immunol 1992;90:646-52.
129. Lilly CM, Hall AE, Rodger IW, et al. Substance P-induced histamine release in tracheally perfused guinea pig lungs. J Appl Physiol 1995;78:1234-41.
130. Howarth PH, Djukanovic R, Wilson JW, et al. Mucosal nerves in endobronchial biopsies in asthma and non-asthma. Int Arch Allergy Appl Immunol 1991;94:330-3.
131. Cardell LO, Uddman R, Edvinsson L. Low plasma concentrations of VIP and elevated levels of other neuropeptides during exacerbations of asthma. Eur Respir J 1994;7:2169-73.
132. Tomaki M, Ichinose M, Miura M. Elevated substance P content in induced sputum from patients with asthma and patients with chronic bronchitis. Am J Respir Crit Care Med 1995;151:613-7.
133. Forsythe P, McGarvey LP, Heaney LG, et al. Sensory neuropeptides induce histamine release from bronchoalveolar lavage cells in both nonasthmatic coughers and cough variant asthmatics. Clin Exp Allergy 2000;30:225-32.
134. Stead RH, Dixon MF, Bramwell NH, et al. Mast cells are closely apposed to nerves in the human gastrointestinal mucosa. Gastroenterology 1989;97:575-85.
135. Shanahan F, Denburg JA, Fox J, et al. Mast cell heterogeneity: effects of neuroenteric peptides on histamine release. J Immunol 1985;135:1331-7.
136. Barbara G, Stanghellini V, De Giorgio R, et al. Activated mast cells in proximity to colonic nerves correlate with abdominal pain in irritable bowel syndrome. Gastroenterology 2004;126:693-702.
137. Jiang W, Kreis ME, Eastwood C, et al. 5-HT3 and histamine H1 receptors mediate afferent nerve sensitivity to intestinal anaphylaxis in rats. Gastroenterology 2000;119:1267-75.
138. McKay DM, Bienenstock J. The interaction between mast cells and nerves in the gastrointestinal tract. Immunol Today 1994;15:533-8.
139. Perdue MH, Masson S, Wershil BK, Galli SJ. Role of mast cells in ion transport abnormalities associated with intestinal anaphylaxis: correction of the diminished secretory response in genetically mast cell-deficient W/Wv mice by bone marrow transplantation. J Clin Invest 1991;87:687-93.
140. Javed NH, Wang YZ, Cooke HJ. Neuroimmune interactions: role for cholinergic neurons in intestinal anaphylaxis. Am J Physiol 1992;263: G847-52.
141. Wershil BK, Castagliuolo I, Pothoulakis C. Direct evidence of mast cell involvement in Clostridium difficile toxin A-induced enteritis in mice. Gastroenterology 1998;114:956-64.
142. Castagliuolo I, LaMont JT, Letourneau R, et al. Neuronal involvement in the intestinal effects of Clostridium difficile toxin A and Vibrio cholerae enterotoxin in rat ileum. Gastroenterology 1994;107:657-65.
143. Barnes PJ. Cytokine modulators as novel therapies for airway disease. Eur Respir J Suppl 2001;34:67s-77s.
144. Toyoda M, Morohashi M. Morphological assessment of the effects of cyclosporin A on mast cell-nerve relationship in atopic dermatitis. Acta Derm Venereol 1998;78:321-5.
145. Mazelin L, Theodorou V, Fioramonti J, Bueno L. Vagally dependent protective action of calcitonin gene-related peptide on colitis. Peptides 1999;20:1367-74.
146. Reinshagen M, Patel A, Sottili M, et al. Action of sensory neurons in an experimental rat colitis model of injury and repair. Am J Physiol 1996;270(1 Pt 1):G79-86.
147. Miampamba M, Sharkey KA. Distribution of calcitonin gene-related peptide, somatostatin, substance P, and vasoactive intestinal polypeptide in experimental colitis in rats. Neurogastroenterol Motil 1998;10:315-29.
148. Lambrecht BN, Germonpre PR, Everaert EG, et al. Endogenously produced substance P contributes to lymphocyte proliferation induced by dendritic cells and direct TCR ligation. Eur J Immunol 1999;29:3815-25.
149. Weinstock JV, Blum A, Walder J, Walder R. Eosinophils from granulomas in murine schistosomiasis mansoni produce substance P. J Immunol 1988;141:961-6.
150. Maggi CA. The effects of tachykinins on inflammatory and immune cells. Regul Pept 1997;70:75-90.